⚕ GalenOps CRO console
← SITE012 (BRA)

SITE012-0164

completed
Study: A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer Phase III · Site: SITE012 (BRA) (Dr. Kowalski) · consented 2022-09-10
Adverse events
9
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

severe assessed 2026-08-18

Grade 3 Colitis — outcome: RECOVERED/RESOLVED; onset 2022-10-17 (study day 24); relationship: not assessed

mild assessed 2026-08-18

Grade 1 Peripheral neuropathy — outcome: RECOVERED/RESOLVED; onset 2022-11-25 (study day 63); relationship: not assessed

mild assessed 2026-08-18

Grade 1 Peripheral neuropathy — outcome: RECOVERED/RESOLVED; onset 2023-03-13 (study day 171); relationship: Y

mild assessed 2026-08-18

Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2023-08-17 (study day 328); relationship: not assessed

moderate assessed 2026-08-18

Grade 2 Neutropenia — outcome: UNKNOWN; onset 2023-10-14 (study day 386); relationship: N

mild assessed 2026-08-18

Grade 1 Decreased appetite — outcome: RECOVERED/RESOLVED; onset 2023-12-20 (study day 453); relationship: N

mild assessed 2026-08-18

Grade 1 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2023-12-25 (study day 458); relationship: not assessed

mild assessed 2026-08-18

Grade 1 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2024-01-02 (study day 466); relationship: not assessed

moderate assessed 2026-08-18

Grade 2 Anaemia — outcome: RECOVERED/RESOLVED; onset 2024-03-19 (study day 543); relationship: N

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.